lunes, 16 de febrero de 2026

Acanthosis Nigricans With Germline EGFR L858R Variant Responds to Targeted Therapy John Jesitus February 16, 2026

https://www.medscape.com/viewarticle/acanthosis-nigricans-germline-egfr-l858r-variant-responds-2026a10004ui

No hay comentarios:

Publicar un comentario